未登录

Y

Yanmei Lu

Xinjiang Medical University

H指数:14

被引数:850

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Computed Tomography-Verified Pacing Location of Micra Leadless Pacemakers and Characteristics of Paced Electrocardiograms in Bradycardia Patients

经计算机断层扫描验证的Micra无导线起搏器起搏位置及缓慢性心律失常患者起搏心电图特征

CLINICAL CARDIOLOGY

IF2.3

2025-10-071

OAAI

Clinical value of combining epirubicin with mindfulness intervention in patients with urinary system tumors and depression

world psychiatry

IF3.4

2025-01-190

OA

Hemolysis after pulsed-field ablation of atrial fibrillation

心房颤动脉冲场消融后的溶血

IF5.7

2025-01-010

PRE

MCPIP1 promotes atrial remodeling by exacerbating miR-26a-5p/FRAT/Wnt axis-mediated atrial fibrosis in a rat model susceptible to atrial fibrillation

MCPIP1通过加重miR-26a-5p/FRAT/Wnt轴介导的心房纤维化促进大鼠心房重构

IF4.2

2024-09-200

PRE

Neuroimmune modulation mediated by IL-6: A potential target for the treatment of ischemia-induced ventricular arrhythmias

IF5.7

2024-05-016

PRE

A 3-month gene therapy single-dose IV administration pharmacology and safety study with ST-920 (isaralgagene civaparvovec) for Fabry disease in mice

MOLECULAR GENETICS AND METABOLISM

IF3.5

2024-02-010

PRE

Analysis of Gb3 inclusions in kidney biopsies as a biomarker supporting the ST-920 phase 1/2 clinical trial for Fabry disease

MOLECULAR GENETICS AND METABOLISM

IF3.5

2024-02-010

PRE

Anti-AAV6 antibody assay for patient enrollment supporting ST920 phase 1/2 study for Fabry disease

MOLECULAR GENETICS AND METABOLISM

IF3.5

2024-02-010

PRE

Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2-inactivated vaccine

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-06-292

OAAI

A Woman With Recurrent Syncope and Malar Flush in the Setting of a Left Atrial Echogenic Mass

JAMA CARDIOLOGY

IF14.1

2023-06-010

PRE

Increased?1-adrenergic receptor antibody confers a vulnerable substrate for atrial fibrillation via mediating Ca2+ mishandling and atrial fibrosis in active immunization rabbit models

CLINICAL SCIENCE

IF7.7

2023-01-278

OAAI

Radiofrequency ablation of hypertrophic obstructive cardiomyopathy-a potential method for clinical application

INTERNATIONAL JOURNAL OF CARDIOLOGY

IF3.2

2022-12-011

PRE

In Vitro Drug Screening Using iPSC-Derived Cardiomyocytes of a Long QT-Syndrome Patient Carrying KCNQ1 & TRPM4 Dual Mutation: An Experimental Personalized Treatment

IF5.2

2022-08-117

OAAI

Optimization for ultrasonic-microwave synergetic extraction of total iridoid glycosides and screening of analgesic and anti-inflammatory active fractions from patrinia scabra Bunge (Valerianaceae)

BMC COMPLEMENTARY MEDICINE AND THERAPIES

IF3.4

2022-01-044

OAAI

When using the left atrial appendage occlusion device, atrial fibrillation itself should not be ignored

使用左心耳封堵装置时，不应忽视房颤本身

INTERNATIONAL JOURNAL OF CARDIOLOGY

IF3.2

2022-01-010

PRE

The effect of Beta-blocker on sudden cardiac death in arrhythmogenic right ventricle cardiomyopathy remains to be considered

INTERNATIONAL JOURNAL OF CARDIOLOGY

IF3.2

2021-12-010

PRE

Cholinergic Elicitation Prevents Ventricular Remodeling via Alleviations of Myocardial Mitochondrial Injury Linked to Inflammation in Ischemia-Induced Chronic Heart Failure Rats

MEDIATORS OF INFLAMMATION

IF4.2

2021-11-207

OAAI

Insomnia Promotes Hepatic Steatosis in Rats Possibly by Mediating Sympathetic Overactivation

FRONTIERS IN PHYSIOLOGY

IF3.4

2021-09-246

OAAI

Homogeneous and noncovalent immobilization of NHC-Cu catalyzed azide-alkyne cycloaddition reaction

MOLECULAR CATALYSIS

IF4.9

2021-03-014

PREAI

Characterization of the selective in vitro and in vivo binding properties of crenezumab to oligomeric Aβ

ALZHEIMERS RESEARCH & THERAPY

IF7.6

2019-12-0131

OAAI